Affidea CEO interview with Torino Magazine, Italy "We use the best technology and the best medical know-how, built on the unique skills of over 9 thousand people…committed to serving over 10 million patients a year to the highest clinical standards.”
(translation of original article)
Bigger and bigger. Also in Italy
AFFIDEA, EUROPE'S LARGEST PROVIDER OF DIAGNOSTIC IMAGING, OUTPATIENT AND CANCER CARE SERVICES, CONTINUES TO INVEST IN THE ITALIAN MARKET, DESPITE THE PANDEMIC. IN PIEDMONT, THE ACQUISITION OF CDC GROUP WAS STRATEGIC, WHILST THE ACTIVITY OF THE AFFIDEA IRMET MEDICAL HUB CONTINUES
Affidea is the largest body of diagnostic imaging, outpatient and cancer care services, present in 15 countries in Europe, with 319 centers. Giuseppe Recchi, CEO of the Affidea Group, explains: "We use the best technology and the best medical know-how, built on the unique skills of over 9 thousand people, of whom 50% are doctors committed to serving over 10 million patients a year to the highest clinical standards. There is no competitor in Europe with such a high number of poly-diagnostic centers nor, above all, with the ability to manage a fleet of over 1400 diagnostic machines, equal in number to health services of entire countries. With a diverse range of clinical expertise, top medical professionals and a broad presence across Europe, Affidea is uniquely positioned to lead the expansion of integrated care and deliver high-quality patient-centric services."
Italy, which is one of the markets with the highest clinical quality for health services in Europe, represents a strategic asset for Affidea. In the last 2 years it has become the main operator, with 57 centers that offer integrated services: from preventive medicine to specialist consultations, laboratory analysis, diagnostic imaging and cancer treatment, to adjacent services, such as dentistry, aesthetic medicine and the most recent section added to the network, a medical sports center for athletes in Lombardy. "Piedmont is also a key region in the Affidea Italia network. The acquisition of CDC Group marked a significant advantage in Affidea's growth strategy this year, accelerating our transformation journey to provide an integrated model for outpatient care and digital imaging services, building the ability to offer our patients an integrated service of the highest quality. Thanks to the expertise and entrepreneurial culture of CDC and its staff, we have doubled our size in the country and built a diversified portfolio of medical services with a strengthened capacity in corporate health services. This makes Affidea one of the preferred healthcare providers for companies and private health insurers. Affidea Italia and CDC bring together over 2500 professionals, of which 2000 are medical staff, serving over 2.2 million patients a year.
3D breast volumetric ultrasound
TC Cone Beam
At the same time, the activity of the IRMET center continues, a high-tech medical hub for Affidea, where 3 million euros have been invested in cutting-edge medical technologies for cancer detection this year alone, with the installation of the latest PET-CT and SPECT-CT digital machines. The new instrumentation allows for accurate identification of the smallest lesions, also allowing a more precise monitoring of diseases over time in the fields of oncology, neurology and cardiology. IRMET remains one of the centers of excellence in cancer detection thanks not only to its fleet of state-of-the-art equipment, but also to its approach to innovation and its exceptional clinical team.
Here SubtlePET was successfully piloted, a software that uses an AI algorithm to improve the quality of PET/CT images, which were acquired with a reduced dose or reduced scanning times. "We are confident that the reduction in scan time will bring a significant benefit to large cancer hospitals, which have long waiting lists for PET-CT scans and need a trusted partner. In this way, we are best placed to increase patient access to this examination, offering our support to the National Health Service and public hospitals."
Nothing is more important than health.
This is Affidea. Affidea is a leading pan-European healthcare group in the sector, specialized in the provision of advanced diagnostics, outpatient specialist services, laboratory analysis, physiotherapy and the rehabilitation, diagnosis and treatment of cancer. It is present in 15 European countries, with 319 centers